Prognostic and predictive value of metabolic tumor volume on 18F-FDG PET/CT in advanced biliary tract cancer treated with gemcitabine/oxaliplatin with or without erlotinib
Crossref DOI link: https://doi.org/10.1007/s12032-014-0023-7
Published Online: 2014-06-10
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Choi, Moon Ki
Choi, Joon Young
Lee, Jeeyun
Heo, Jin Seok
Choi, Seong Ho
Choi, Dong Wook
Lee, Kyu Taek
Lee, Jong Kyun
Lee, Kwang Hyuck
Park, Joon Oh
Park, Young Suk
Lim, Ho Yeong
Text and Data Mining valid from 2014-06-10